Risk Factors

. Y. Sun, L., Zghebi, S. S., Eddeen, A. B., Liu, P. P., Lee, D. S., Tu, K., et al. (2022). Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients With Incident Diabetes. Diabetes Care, 45, 2737-2745. http://doi.org/10.2337/dc22-0894
Elwenspoek, M. M., Thom, H., Sheppard, A. L., Keeney, E., O'Donnell, R., Jackson, J., et al. (2022). Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Health Technol Assess, 26, 1-310. http://doi.org/10.3310/zuce8371
Conrad, N., Verbeke, G., Molenberghs, G., Goetschalckx, L., Callender, T., Cambridge, G., et al. (2022). Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet, 400, 733-743. http://doi.org/10.1016/s0140-6736(22)01349-6
Cipolletta, E., Tata, L. J., Nakafero, G., Avery, A. J., Mamas, M. A., & Abhishek, A. (2022). Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout. Jama, 328, 440-450. http://doi.org/10.1001/jama.2022.11390
Aoki, Y., Cabrera, C. S., Ouwens, M., Bamberg, K., Nyström, J., Raz, I., et al. (2022). Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data. Plos One, 17, e0269970. http://doi.org/10.1371/journal.pone.0269970
Abenhaim, H. A., Suissa, S., Azoulay, L., Spence, A. R., Czuzoj-Shulman, N., & Tulandi, T. (2022). Menopausal Hormone Therapy Formulation and Breast Cancer Risk. Obstet Gynecol, 139, 1103-1110. http://doi.org/10.1097/aog.0000000000004723
Livingstone, S. J., Guthrie, B., Donnan, P. T., Thompson, A., & Morales, D. R. (2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. Bmc Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6
Danese, M., Sidelnikov, E., Villa, G., Catterick, D., Iqbal, M., Gleeson, M., et al. (2022). Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK. Bmj Open, 12, e055015. http://doi.org/10.1136/bmjopen-2021-055015
Dziopa, K., Asselbergs, F. W., Gratton, J., Chaturvedi, N., & Schmidt, A. F. (2022). Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings. Diabetologia, 65, 644-656. http://doi.org/10.1007/s00125-021-05640-y
Strongman, H., Carreira, H., De Stavola, B. L., Bhaskaran, K., & Leon, D. A. (2022). Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink. Plos Med, 19, e1003870. http://doi.org/10.1371/journal.pmed.1003870